Accuray | ARAY - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
Accuray USD 124.78M 2.54M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 84.55M 6.21M 2026-03
Boston Scientific USD 1.78B 53M 2026-03
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Inogen USD 43.77M 510K 2024-06
Mesa Laboratories USD 27.31M 380K 2024-09
Orthofix International USD 130.35M 11.31M 2025-12
Surmodics USD 11.4M 3.18M 2025-06
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Trinity Biotech USD 6.19M 2.18M 2025-09